Instituto Nacional De Cancerologia De Mexico
Clinical trials sponsored by Instituto Nacional De Cancerologia De Mexico, explained in plain language.
-
Heart drug may help radiation fight brain tumors in lung cancer patients
Disease control Recruiting nowThis study tests whether adding a nitroglycerin patch (a heart medication) to standard radiation therapy can better shrink brain tumors in people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the brain. About 74 adults will receiv…
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Diabetes drug metformin may boost lung cancer treatment in new trial
Disease control Recruiting nowThis phase 3 study tests whether adding the diabetes drug metformin to standard targeted therapy (tyrosine kinase inhibitors) can help control advanced non-small cell lung cancer with EGFR mutations. About 312 adults with stage IIIB or IV lung cancer will receive either metformin…
Phase: PHASE3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New study seeks best dose of targeted drug for ALK lung cancer
Disease control Recruiting nowThis study is for people with advanced ALK-positive non-small cell lung cancer. It tests three different doses of the drug alectinib to see how the body processes each dose and which dose works best. The goal is to find the safest and most effective dose to control the cancer.
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Gut shield: new diet aims to stop cancer drug side effect
Prevention Recruiting nowThis study tests whether adding glutamine and a probiotic (Lactobacillus reuteri) to a bland diet can prevent diarrhea caused by targeted therapy (TKIs) in people with advanced EGFR-mutant non-small cell lung cancer. About 28 participants will either receive the supplemented diet…
Phase: PHASE3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Prevention
Last updated May 08, 2026 12:01 UTC
-
Can a simple inhaler shield lung cancer patients from radiation side effects?
Symptom relief Recruiting nowThis study tests whether using inhaled steroids before and during radiation therapy can lower the risk and severity of lung inflammation (pneumonitis) in people with advanced non-small cell lung cancer. About 72 participants will receive either the inhaled steroid or a placebo al…
Phase: PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Symptom relief
Last updated May 17, 2026 00:59 UTC
-
Lung rehab may boost strength and survival in advanced cancer
Symptom relief Recruiting nowThis study looks at whether a pulmonary rehabilitation program can help people with advanced non-small-cell lung cancer maintain muscle mass, improve lung function, and reduce inflammation. About 94 participants will take part while receiving standard cancer treatments like chemo…
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Symptom relief
Last updated May 17, 2026 00:50 UTC
-
New scale aims to track lung cancer Patients' rehab commitment
Knowledge-focused Recruiting nowThis study is creating a questionnaire to measure how closely lung cancer patients follow their respiratory rehabilitation program. About 281 Mexican adults with lung cancer will fill out the 56-question scale. The goal is to make sure the tool is accurate and reliable, so doctor…
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 17, 2026 01:04 UTC
-
Can a simple scan catch lung cancer before It's too late? mexico launches major study
Knowledge-focused Recruiting nowThis study is testing whether yearly low-dose CT scans can help find lung cancer early in 1,000 high-risk adults in Mexico. Participants are 50 or older and are heavy smokers, former smokers, or have been exposed to wood smoke. The goal is to see if this screening method can catc…
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Can your body shape predict chemo toxicity? new study investigates
Knowledge-focused Recruiting nowThis study looks at how a person's muscle mass (fat-free mass) relates to side effects from standard chemotherapy (carboplatin/paclitaxel) in advanced non-small cell lung cancer. Researchers will track 132 participants to see if adjusting the chemo dose based on body composition …
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC